VDOT for Monitoring Adherence to LTBI Treatment

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

March 8, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
TuberculosisLatent Tuberculosis Infection
Interventions
OTHER

Video Directly Observed Therapy

Video Directly Observed Therapy (VDOT) is a novel means of remotely observing patients ingesting medications using videos sent from a smartphone. VDOT was developed and found to be feasible and acceptable for monitoring daily treatment of active TB in San Diego, CA and Tijuana, B.C., Mexico (R21-AI088326; PI: R. Garfein). Patients are taught how to use the VDOT recording app, record medication ingestion, and contact their physician when side effects occur. Participants are trained at the time of their first LTBI treatment dose to ensure participants know how to record videos. All remaining 11 weekly doses are taken and recorded wherever the participant chooses. Clinic staff monitor videos as they arrive using a password protected website and document each medication dose that is taken.

OTHER

In-Person DOT

Clinic-based, in-person DOT is the standard of care for monitoring adherence for patients taking the 12-dose isoniazid/rifapentine treatment for LTBI. Participants visit the clinic once weekly until all 12 doses are taken or 16 weeks pass, whichever comes first.

Trial Locations (1)

92110

San Diego County Health and Human Services Agency, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02641106 - VDOT for Monitoring Adherence to LTBI Treatment | Biotech Hunter | Biotech Hunter